425 Merger communication
- Filed
- Accession number
- 0001213900-26-080417
Documents
Exhibits
- 10.1 Amendment No. 1 to Securities Purchase Agreement, Dated as of July 22, 2026, by and Among Mentari Therapeutics, Inc. and the Investors Party Thereto EX-10.1
- 99.1 Press Release, Issued on July 22, 2026 EX-99.1